CAS: 211364-06-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AT 130 REF: 4Z-B-118003CAS: 211364-06-6 | - - - | To inquire | Thu 30 May 24 |
 | AT-130 REF: TM-T26674CAS: 211364-06-6 | 98.62% | 72.00 €~922.00 € | Thu 30 May 24 |
 | AT-130 REF: 3D-LIA36406CAS: 211364-06-6 | Min. 95% | To inquire | Fri 05 Jul 24 |
Ref: 4Z-B-118003
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 30 May 2024
AT-130
CAS:211364-06-6
AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced …
Formula:
C22H22BrN3O5
Purity:
98.62%
Color and Shape:
Solid
Molecular weight:
488.33
Ref: TM-T26674
| 1mg | 72.00 € | |
| 5mg | 158.00 € | |
| 10mg | 292.00 € | |
| 25mg | 464.00 € | |
| 50mg | 672.00 € | |
| 100mg | 922.00 € | |
| 1ml*10 (DMSO) | 171.00 € |
Estimated delivery in United States, on Thursday 30 May 2024
AT-130
CAS:211364-06-6
AT-130 is a peptide that binds to the CCR5 receptor, which is found on the …
Formula:
C22H22BrN3O5
Purity:
Min. 95%
Molecular weight:
488.3 g/mol
Ref: 3D-LIA36406
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Friday 5 Jul 2024
